Rocket Lab (RKLB) Stock Drops 8% — Classic Sell-the-News After Nasdaq-100 Add

TLDR

• RKLB fell 8.33% after its addition to the Nasdaq-100 sparked a “sell-the-news” pullback
• The drop was deepened by rotation out of space stocks following the recent SpaceX IPO
• Q1 revenue hit $200.35 million, up 63.4% year over year, beating estimates
• HSBC boosted its RKLB stake by 613.9% in Q4, acquiring 1.35 million additional shares
• Insiders sold 573,515 shares worth over $76 million in the last 90 days

Rocket Lab (RKLB) opened at $107.24 on Monday, down 8.33% on the session. The drop comes after its long-awaited inclusion in the Nasdaq-100 Index triggered a classic “sell-the-news” reaction.

Rocket Lab USA, Inc., RKLB

The stock had rallied hard into the index addition on speculation. Once it became official, sellers stepped in — a pattern that plays out regularly when anticipated catalysts finally arrive.

The pullback was compounded by a broader rotation out of space sector names. The recent SpaceX IPO appears to have pulled attention and capital away from smaller space plays, adding pressure across the board.

Despite the drop, the business itself keeps moving. Rocket Lab is currently integrating the payload for its 90th Electron mission, a milestone that underlines just how far its launch cadence has come.

On the financials, Q1 was solid. Revenue came in at $200.35 million, up 63.4% year over year and ahead of the $189.65 million analyst consensus. EPS matched forecasts at -$0.07, improving from -$0.12 in the same quarter a year ago.

The company still runs at a loss, with a net margin of -26.87% and a negative return on equity of 11.72%. Analysts expect full-year EPS of -$0.29.

Institutional Interest Remains Strong

Not everyone is heading for the exit. HSBC Holdings increased its RKLB position by 613.9% in Q4, picking up 1.35 million additional shares. Its total holding now stands at 1.57 million shares, valued at around $110.7 million at the time of the SEC filing.

Other institutions made smaller additions. Sara Bay Financial, ORG Partners, Traynor Capital, Capital Advisors Wealth Management, and Quadcap Wealth Management all increased their positions during Q4. Overall, 71.78% of RKLB is held by institutional investors.

Analysts currently rate the stock a Moderate Buy with an average price target of $102.76 — below Monday’s open, which gives some context to the recent selling.

Insider Activity Draws Attention

While institutions were buying in Q4, insiders have been selling in 2025. Over the last 90 days, insiders offloaded 573,515 shares for a combined value of $76.4 million.

Insider Frank Klein sold 36,860 shares on May 28 at an average price of $147.42, totalling $5.43 million. Fellow insider Marvin Bradford Clevenger sold 3,500 shares the same day at $146.67. Both sales were executed under pre-arranged Rule 10b5-1 trading plans.

The 52-week range for RKLB sits between $27.84 and $151.00. The stock’s 50-day moving average is $105.58, and its 200-day moving average is $83.61. Year-to-date, RKLB is still up 53.73%.

The company carries a market cap of $62.07 billion, a debt-to-equity ratio of 0.02, and a beta of 2.48 — a reminder that this is a high-volatility name. RKLB’s current ratio stands at 4.47, with a quick ratio of 4.02.

The post Rocket Lab (RKLB) Stock Drops 8% — Classic Sell-the-News After Nasdaq-100 Add appeared first on CoinCentral.